(Q54269263)

27 May 2018

title

Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis. (English)

1 reference

27 May 2018

main subject

hepatocellular carcinoma

1 reference

1 reference

Xinyu Qiu

1

1 reference

27 May 2018

Jianyong Zheng

2

1 reference

27 May 2018

Xiaodong Guo

3

1 reference

27 May 2018

Xingchun Gao

4

1 reference

27 May 2018

Hui Liu

5

1 reference

27 May 2018

Yanyang Tu

6

1 reference

27 May 2018

Yongsheng Zhang

7

1 reference

27 May 2018

publication date

11 March 2013

1 reference

27 May 2018

Molecular and Cellular Biochemistry

published in

1 reference

27 May 2018

volume

378

1 reference

27 May 2018

issue

1-2

1 reference

27 May 2018

page(s)

99-106

1 reference

27 May 2018

Global cancer statistics, 2002

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Regulation of cytokine signaling by SOCS family molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

The SOCS box: a tale of destruction and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

SOCS: role in inflammation, allergy and homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

SOCS2 can enhance interleukin-2 (IL-2) and IL-3 signaling by accelerating SOCS3 degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Differential roles of SOCS family members in EpoR signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

SOCS2 induces neurite outgrowth by regulation of epidermal growth factor receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Overexpression of SOCS-2 in advanced stages of chronic myeloid leukemia: possible inadequacy of a negative feedback mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Differential hypermethylation of SOCS genes in ovarian and breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

The nuclear localization of SOCS6 requires the N-terminal region and negatively regulates Stat3 protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Identification of suppressor of cytokine signalling (SOCS) 6, 7, 9 and CISH in rainbow trout Oncorhynchus mykiss and analysis of their expression in relation to other known trout SOCS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Suppressor of cytokine signaling 6 (SOCS6) promotes mitochondrial fission via regulating DRP1 translocation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Array-comparative genomic hybridization reveals loss of SOCS6 is associated with poor prognosis in primary lung squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Prognostic and predictive relevance of DNAM-1, SOCS6 and CADH-7 genes on chromosome 18q in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

SOCS6, down-regulated in gastric cancer, inhibits cell proliferation and colony formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Favorable prognostic value of SOCS2 and IGF-I in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Evolution of the androgen receptor pathway during progression of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

Suppressor of cytokine signalling gene expression is elevated in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1599-5

SOCS5 and SOCS6 have similar expression patterns in normal and cancer tissues

21 January 2018

1 reference

12 December 2020

Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array

1 reference

12 December 2020

Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis

1 reference

12 December 2020

Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma

1 reference

12 December 2020

The endogenous interferon system in anal squamous epithelial lesions with different grades from HIV-positive individuals

1 reference

12 December 2020

10.1007/S11010-013-1599-5

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018